Related Experiment Video

Updated: Mar 5, 2026

Metabolic Labeling of Leucine Rich Repeat Kinases 1 and 2 with Radioactive Phosphate
11:31

Metabolic Labeling of Leucine Rich Repeat Kinases 1 and 2 with Radioactive Phosphate

Published on: September 18, 2013

10.5K

LRRK2 Phosphorylation

R Jeremy Nichols1

  • 1The Parkinson's Institute, Sunnyvale, CA, 94089, USA. jnichols@parkinsonsinstitute.org.

Advances in Neurobiology
|March 30, 2017
PubMed

Insights

Mutations in the leucine-rich repeat kinase 2 (LRRK2) gene are linked to Parkinson's disease. Studying LRRK2 phosphorylation reveals its kinase activity and role in disease mechanisms.

Area of Science:

  • Neuroscience
  • Genetics
  • Biochemistry

Background:

  • Mutations in the leucine-rich repeat kinase 2 (LRRK2) gene are the most common genetic cause of Parkinson's disease.
  • LRRK2 is a multi-domain protein with GTPase and kinase functions, implicated in cellular signaling pathways.
  • LRRK2 is subject to regulation by kinases and phosphatases, existing in various phosphorylated states.

Purpose of the Study:

  • To identify LRRK2 phosphorylation sites.
  • To understand how LRRK2 phosphoregulation influences its kinase activity, ubiquitination, and localization.
  • To gain insight into LRRK2 dysfunction in Parkinson's disease.

Main Methods:

  • Identification of LRRK2 phosphorylation sites.
  • In vitro, cellular, and tissue-based analyses of LRRK2 phosphorylation.
  • Assessment of LRRK2 kinase activity, ubiquitination, and localization.

Main Results:

  • Differential phosphorylation of LRRK2 serines (910/935/955/973) in pathogenic mutations and after kinase inhibition.
  • Phosphoregulation of LRRK2 impacts its kinase activity.
  • Phosphorylation status affects LRRK2 ubiquitination and cellular localization.

Conclusions:

  • The phosphorylation status of LRRK2 provides critical insights into kinase dysfunction in Parkinson's disease.
  • Understanding LRRK2 phosphoregulation is key to elucidating its role in disease pathogenesis.
  • This research highlights LRRK2 phosphorylation as a potential therapeutic target for Parkinson's disease.
Keywords:
DephosphorylationDeubiquitinaseDeubiquitinationKinaseLRRK2Parkinson’s diseasePhosphatasePhosphorylationPosttranslational modificationSignal transductionSynucleinUbiquitin ligaseUbiquitination

More Related Videos

Assaying the Kinase Activity of LRRK2 in vitro06:09

Assaying the Kinase Activity of LRRK2 in vitro

Published on: January 18, 2012

23.0K
Rab10 Phosphorylation Detection by LRRK2 Activity Using SDS-PAGE with a Phosphate-binding Tag08:55

Rab10 Phosphorylation Detection by LRRK2 Activity Using SDS-PAGE with a Phosphate-binding Tag

Published on: December 14, 2017

16.2K

Related Concept Videos

PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
6.0K
Receptor Tyrosine Kinases01:26

Receptor Tyrosine Kinases

Receptor tyrosine kinases or RTKs are membrane-bound receptors that phosphorylate specific tyrosine on protein substrates. RTKs regulate cellular growth, differentiation, survival, and migration. They contain an extracellular ligand binding domain, a transmembrane domain, and a cytosolic tail with intrinsic kinase activity. Several extracellular signaling molecules activate RTKs in one or more ways and relay the signal downstream. Ligands such as platelet-derived growth factor (PDGF) or...
20.1K
Phosphorylation01:02

Phosphorylation

The addition or removal of phosphate groups from proteins is the most common chemical modification that regulates cellular processes. These modifications can affect the structure, activity, stability, and localization of proteins within cells as well as their interactions with other proteins.
During phosphorylation, protein kinases transfer the terminal phosphate group of ATP to specific amino acid side chains of substrate proteins. Serine, threonine, and tyrosine are the most commonly...
55.0K
Protein Kinases and Phosphatases02:54

Protein Kinases and Phosphatases

Proteins undergo chemical modifications that trigger changes in the charge, structure, and conformation of the proteins. Phosphorylation, acetylation, glycosylation, nitrosylation, ubiquitination, lipidation, methylation, and proteolysis are various protein modifications that regulate protein activity. Such modifications are usually enzyme-driven.
Protein kinases
Many proteins in the cell are regulated by phosphorylation, the addition of a phosphate group. A family of enzymes called kinases...
15.4K
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
8.9K
Regulation of the Unfolded Protein Response01:31

Regulation of the Unfolded Protein Response

Inositol-requiring kinase one or IRE1 is the most conserved eukaryotic unfolded protein response (UPR) receptor. It is a type I transmembrane protein kinase receptor with a distinctive site-specific RNase activity. As the binding mechanics of the misfolded proteins with the N-terminal domain of IRE-1 are unclear, three binding models — direct, indirect, and allosteric -- are proposed for receptor activation. Nevertheless, it is known that once a misfolded protein associates with IRE1, it...
3.1K